Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
---|
01/16/2002 | EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
01/16/2002 | EP1006984A4 Monohydric alcohol derived urethanes and their use in cosmetic formulations |
01/15/2002 | US6339154 (2-Substituted oxyphenyl) alkanamide derivative, hair growth promoter and external composition for skin using the same |
01/15/2002 | US6339103 For applying to plants, seeds |
01/10/2002 | WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM |
01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
01/09/2002 | EP1170287A1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids |
01/09/2002 | EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof |
01/09/2002 | EP1169298A2 Pharmaceutical compounds |
01/09/2002 | EP0778263B1 Benzene compound and medicinal use thereof |
01/09/2002 | CN1330649A Herbicidal-3-[benzo(ox/thi)azol-7-yl)-1H-pyrimidine-2,4-diones |
01/09/2002 | CN1330637A Compounds useful in treatment of infammatory diseases |
01/09/2002 | CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their |
01/09/2002 | CN1077570C Sulfamate compounds containing N-substituted carbanoyl and process for preparing the same |
01/09/2002 | CN1077567C Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol |
01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
01/08/2002 | CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
01/03/2002 | WO2002000611A2 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
01/03/2002 | WO2002000610A1 Fluoroalkyloxy dispersant |
01/03/2002 | WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
01/03/2002 | US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them |
01/03/2002 | US20020002196 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye |
01/03/2002 | DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
01/03/2002 | DE10029139A1 Verfahren zur Herstellung von Amiden oder Estern A process for producing amides or esters |
01/03/2002 | CA2415873A1 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
01/02/2002 | EP1167346A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient |
01/02/2002 | EP1166781A1 Proteasome inhibitors |
01/02/2002 | EP1165495A1 Resorcinol derivatives |
01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
01/02/2002 | EP0996627A4 Method for solution phase synthesis of oligonucleotides and peptides |
01/02/2002 | EP0873308B1 O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts |
01/01/2002 | US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function |
01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
01/01/2002 | CA2083149C Intermediate used for the preparation of deferoxamine |
12/27/2001 | WO2001098235A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
12/27/2001 | WO2001063345A9 Photochemically controlled photonic crystal diffraction |
12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
12/27/2001 | US20010055620 Compaction; particle coatings |
12/25/2001 | US6333427 Extracting optically active form of n-t-butoxycarbonylphenylalanine ester in crude preparation into aliphatic hydrocarbon, recovering ester preparation having improved optical purity |
12/25/2001 | US6333426 Chiral adsorbents and preparation thereof as well as compounds on which the absorbents are based and preparation of the compounds |
12/25/2001 | US6333176 Enzymatic cleavage of c-terminal amino group from peptide amide, deamination with peptide amidase, incubation and inoculation |
12/25/2001 | CA2020988C Acid etch resistant coatings |
12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
12/20/2001 | WO2001096282A1 Method for producing amides or esters |
12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
12/20/2001 | WO2001051456A3 Antibacterial agents |
12/20/2001 | US20010053855 Modified alkoxycarbonyloxypyridine as oligonucleotide blocking agent |
12/20/2001 | DE10028764A1 Carbamate compound, useful as a fragrant additive for cleaning, washing and dishwashing agents, is prepared by reaction of free isocyanate group containing compound with fragrant alcohol |
12/19/2001 | EP1164126A1 Salicylic acid hydrazide derivatives, process and intermediates for their preparation, agents containing them and their use for combatting damaging fungi |
12/19/2001 | EP1164125A1 Adamantane derivatives and processes for the preparation thereof |
12/19/2001 | EP1163262A1 Phenylalanine derivatives |
12/19/2001 | EP1162949A1 Urethane surfactants and their use in personal care formulations |
12/19/2001 | EP0951496B1 Alkyd and aralkyd derivatives of phenolic polymers |
12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
12/19/2001 | CN1326930A Method for producing cyclic compounds |
12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
12/18/2001 | US6331566 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
12/18/2001 | US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use |
12/18/2001 | US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases |
12/18/2001 | US6331542 Protease inhibitors |
12/13/2001 | WO2001094438A1 Urethane based on organoleptically active aromatic alcohols |
12/13/2001 | WO2001094357A1 Antitumoral compounds |
12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
12/13/2001 | WO2001094299A1 Benzene derivatives |
12/13/2001 | WO2001094294A1 Fungicides |
12/13/2001 | WO2001034129A3 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
12/13/2001 | US20010051725 Directly from a halomethyl alcohol protected amine derivative and an amine or alkyl carbamate substituted halomethyl alcohol without having to isolate the toxic boc-epoxide; high yield of pure enantiomorph |
12/13/2001 | US20010051648 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds |
12/13/2001 | CA2410409A1 Antitumoral compounds |
12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
12/12/2001 | EP1161416A1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists |
12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
12/12/2001 | EP1161233A2 Lxr modulators |
12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
12/12/2001 | EP0778827B1 Process for producing a beta-amino alcohol |
12/12/2001 | CN1325847A Compound with electron providing and receiving functional groups |
12/12/2001 | CN1325845A Solidized hybridized vinyl ether containing electron providing compound |
12/12/2001 | CN1076016C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
12/11/2001 | US6329377 Enzyme inhibitors for nervous system disorders |
12/11/2001 | US6329359 Substituted benzyl oximino compounds |
12/06/2001 | WO2001092372A2 Monofunctional monomers, radically polymerisable compositions containing them and resins and ophtalmic articles obtained from them |
12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
12/06/2001 | WO2001092213A2 Excitatory amino acid receptor modulators |
12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
12/06/2001 | WO2001091897A1 Process and unit for the continuous preparation of isocyanate-containing polyurethane prepolymers |
12/06/2001 | US20010049387 Use in the treatment of cancer, as tubulin polymerizers and as microtubule stabilization agents. |
12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |
12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |